RESUMO
One hundred five patients with hepatoma were treated with iodine 131 antiferritin in three sequential protocols in phase 1-2 trials. Therapy began in all trials with external beam irradiation and chemotherapy. The dosimetric results with 131I antiferritin indicated that 30 mCi (8 to 10 mCi/mg immunoglobulin G [IgG]) was sufficient to saturate the tumor. Tumor-effective half-life of the radioactive antibody was 3 to 5 days and was dependent on the species of animal from which the antibody was derived. This led to a 30 mCi on day 0 and 20 mCi on day 5 treatment schedule. Toxicity was predominantly thrombocytopenia. Due to clinical remission, cyclic therapy was next developed with antibodies from different species of animals. Rabbit, pig, monkey, and bovine antibodies were determined to produce the longest tumor-effective half-life and therefore the highest dose of radiation. Integration of 15 mg doxorubicin and 500 mg 5-fluorouracil (5-FU) with 131I antiferritin was accomplished next. Remission to external beam radiation was evaluated by computed tomography (CT) scan tumor volume computations that indicated that 22% of the patients had a partial remission (PR) from initial presentation to 1 month following external irradiation and chemotherapy. From the time of radioactive antibody administration, 48% of the patients (7% complete response [CR] and 41% PR) achieved remission to 131I antiferritin. Of 79 patients evaluated by CT scan tumor volumetrics 50% of the patients (7% CR and 43% PR) remitted to the entire treatment regimen. Patients not previously treated and without metastasis who were alpha fetoprotein positive (AFP+) had a 5-month median survival compared with AFP- median survival of 10 1/2 months. There were four CRs with one being 3 years and 6 months. The longest PR was 5 years and 8 months. These studies have demonstrated the toxicity and therapeutic activity of 131I antiferritin and the emerging role of radiolabelled antibody in cancer therapy.
Assuntos
Anticorpos Antineoplásicos/uso terapêutico , Braquiterapia/métodos , Carcinoma Hepatocelular/radioterapia , Ferritinas/imunologia , Radioisótopos do Iodo/uso terapêutico , Neoplasias Hepáticas/radioterapia , Adolescente , Adulto , Idoso , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Carcinoma Hepatocelular/diagnóstico por imagem , Terapia Combinada , Avaliação de Medicamentos , Meia-Vida , Doenças Hematológicas/etiologia , Humanos , Imunoglobulina G/isolamento & purificação , Imunoglobulina G/uso terapêutico , Radioisótopos do Iodo/efeitos adversos , Neoplasias Hepáticas/diagnóstico por imagem , Masculino , Pessoa de Meia-Idade , Fatores de Tempo , Tomografia Computadorizada de Emissão , Tomografia Computadorizada por Raios X , alfa-Fetoproteínas/análiseRESUMO
BACKGROUND: Military culture and workplace are areas of interest for researchers across disciplines. However, few publications on military culture exist. OBJECTIVE: The purpose of this article is to introduce general concepts regarding the structure and culture of the United States Military and discuss how this creates challenges for reintegrating into the civilian world. METHOD: Topics that will be covered in this article include an overview of the Department of Defense (DoD) and Department of Veterans Affairs (VA), socialization to military culture, the unique features of the military as a workplace, the cultural experiences of military personnel reintegrating back into the community, and the challenges faced by military members and their spouses. RESULTS: The provided information on military culture will expand military cultural competency so that civilian employers can enhance their ability to create supportive workplaces for veterans and military spouses during times of transition and reintegration. DISCUSSION: The unique characteristics of the military culture should be understood by those who work with or plan to work with military populations.
Assuntos
Militares/psicologia , Cultura Organizacional , Local de Trabalho/psicologia , Humanos , Guerra do Iraque 2003-2011 , Estados UnidosRESUMO
In a previous study we reported that the NSAID sulindac had a marked inhibitory effect on the development of colonic tumours in mice treated with the carcinogen 1,2-dimethylhydrazine (DMH). In this study we examined the effects of sulindac in respect of cell-kinetic changes in mouse colonic mucosa as determined by flash labelling with the thymidine analogue bromodeoxyuridine (BrdUrd) at varying intervals during the process of colonic carcinogenesis. We also investigated the possibility that these changes may be modulated by misoprostol a prostaglandin E1 analogue. Four groups of 36 mice each were treated for 18 weeks with the following drug/s respectively: (1) DMH; (2) DMH and sulindac; (3) DMH, sulindac and misoprostol; and (4) DMH and misoprostol. Three animals from each group were killed each week between the sixth week and the eighteenth week after the start of the experiment. A 1-h flash label technique was employed and paraffin sections of colonic mucosa were examined. For each animal a total of 50 perfect axially cut crypts were chosen and the following parameters determined: crypt length, labelling index and labelling index distribution: the data were analysed using the computer program GLIM. For each of the four groups, crypt lengths increased significantly with the duration of treatment with no significant difference between the groups. In sulindac-treated animals the labelling index for all positions increased with duration of treatment whereas for animals not treated with sulindac there was no significant difference in labelling index with respect to duration of treatment. The administration of misoprostol did not appear to significantly alter the effects of sulindac. It is postulated that the observed increase in cell proliferation could be a compensatory phenomenon occurring secondary to loss of crypt epithelial cells by apoptosis induced by sulindac. Also the finding of an increase in labelling index mediated by a chemopreventive agent indirectly questions the rationale behind the therapeutic manipulation of crypt cell proliferation in order to reduce the risk of colon cancer.
Assuntos
1,2-Dimetilidrazina/toxicidade , Anti-Inflamatórios não Esteroides/farmacologia , Carcinógenos/toxicidade , Mucosa Intestinal/efeitos dos fármacos , Sulindaco/farmacologia , Animais , Divisão Celular/efeitos dos fármacos , Colo , Feminino , Mucosa Intestinal/citologia , Mucosa Intestinal/patologia , Camundongos , Camundongos Endogâmicos BALB C , Misoprostol/farmacologia , Índice Mitótico , Fatores de TempoRESUMO
The in-vitro pharmacokinetics of vincristine (VCR) in normal rat colonic mucosa were studied. Two complementary approaches were adopted using an explant organ-culture system. Firstly [G-3H]vincristine (3HVCR) accumulation, retention and efflux were characterized under basal conditions and compared with measurements made either under energy-depleted conditions, or in the presence of VRP. Secondly, a histological method--the postmetaphase index (PMI)--was used to compare the sensitivity of explants to VCR in the presence or absence of verapamil (VRP). This latter technique involves the measurement, by counting, of the proportion of mitotic figures escaping from metaphase arrest. The studies yielded the following results: 3HVCR accumulation in colonic mucosa showed no evidence of saturability up to the maximum dose studied (130 nM), at a dose of 52 nM accumulation was enhanced in energy-depleted conditions by a factor of 1.8, and in the presence of VRP (6.6 microM) by a factor of 1.4. In the presence of VRP (6.6 microM) retention of 3HVCR was increased by a factor of 1.3 and efflux was reduced by a factor of 0.8 after 2 hr. VRP (6.6 microM) reduced the PMI of colonic mucosal epithelial cells exposed to 11 nM VCR from 18.8% to 11.4% (i.e. 40% reduction) indicating sensitization of the cells to this property of VCR. These results provide evidence that the sensitivity of normal colonic mucosa to vincristine is, at least in part, regulated by drug transport. Qualitatively our observations resemble those described in multidrug resistance. Given that P-glycoprotein has been demonstrated by several groups in colonic mucosal cells, the results support a normal role for this membrane transport molecule in the protection of intestinal cells from plant alkaloids and other xenobiotic agents ingested in the diet.
Assuntos
Colo/efeitos dos fármacos , Metáfase/efeitos dos fármacos , Verapamil/farmacologia , Vincristina/farmacocinética , Animais , Transporte Biológico/efeitos dos fármacos , Colo/metabolismo , Metabolismo Energético/efeitos dos fármacos , Absorção Intestinal , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/metabolismo , Masculino , Técnicas de Cultura de Órgãos , Ratos , Ratos EndogâmicosRESUMO
BACKGROUND: Our objective was to perform a prospective, randomized, double blinded study of cefprozil and penicillin therapy to eradicate group A beta-hemolytic streptococci (GABHS) in children who were bacteriologic failures after receiving a standard 10-day course of penicillin treatment for GABHS pharyngitis. METHODS: Children and adolescents 2 to 18 years of age were eligible for the study. From 3 to 7 days after completing oral penicillin therapy for pharyngitis caused by GABHS, the study was explained, informed consent was obtained, a history and physical examination were completed and a throat culture was performed. Children with throat cultures positive for GABHS were randomized to receive either cefprozil or penicillin for 10 days. Children who were bacteriologic failures after administration of the first study drug were crossed over to receive the alternate drug. RESULTS: Of 180 enrolled children 66 (37%) had throat cultures positive for GABHS. Seventeen were excluded from the study, leaving 49 who completed the protocol. Of the 49 participants 26 received cefprozil initially whereas 23 received penicillin. GABHS were eradicated from the pharynx of 73% of children who received cefprozil as the first antibiotic compared with 39% of penicillin recipients (chi square, 5.748, 0.01 < P < 0.025). After crossover of failures, the final efficacy rate for cefprozil was 65% compared with 36.7% for penicillin (chi square, 5.523, 0.01 < P < 0.025). CONCLUSIONS: Cefprozil was more effective than penicillin in treating children who were bacteriologic failures after a standard 10-day course of oral penicillin.
Assuntos
Antibacterianos/uso terapêutico , Cefalosporinas/uso terapêutico , Penicilinas/uso terapêutico , Faringe/microbiologia , Streptococcus pyogenes/efeitos dos fármacos , Adolescente , Criança , Pré-Escolar , Estudos Cross-Over , Feminino , Humanos , Masculino , CefprozilRESUMO
Nineteen samples of primary colorectal carcinoma and adjacent mucosa were examined for EGFr expression using radioligand binding assays and immunohistochemical staining with the monoclonal antibody EGFR1. Radioligand binding experiments showed expression of EGFr in both tumour and mucosa in all cases. In tumour samples EGFr levels ranged between 4 and 79 fmole per mg membrane protein (Kd = 0.1-0.4 X 10(-9) M). There was no significant difference in the level of EGFr expression between tumour and mucosa overall. Immunohistochemical staining with the EGFR1 antibody was useful in localising EGFr to epithelial elements although it was less sensitive than ligand binding assays.
Assuntos
Neoplasias do Colo/patologia , Receptores ErbB/análise , Neoplasias Retais/patologia , Adenocarcinoma/patologia , Anticorpos Monoclonais , Membrana Celular/metabolismo , Fator de Crescimento Epidérmico/metabolismo , Receptores ErbB/metabolismo , Humanos , Técnicas Imunoenzimáticas , Mucosa Intestinal/patologia , Cinética , Ensaio Radioligante , Fatores de TempoRESUMO
We report an unusual case of bilateral brachial plexus neuritis occurring during the seroconversion stage of an HIV infection in a 45-year-old man. Brachial plexus neuritis is thought to be an immune mediated inflammatory reaction resulting in acute onset of shoulder pain followed by muscle weakness and wasting. There is often a history of viral illness, diagnosis is clinical, and treatment is supportive. Many sufferers are left with residual defects. Clinicians should consider the possibility of HIV infection when managing a patient with brachial plexus neuritis.
Assuntos
Neurite do Plexo Braquial/virologia , Soropositividade para HIV/patologia , Humanos , Masculino , Pessoa de Meia-IdadeAssuntos
Anticorpos/administração & dosagem , Carcinoma Hepatocelular/radioterapia , Neoplasias Hepáticas/radioterapia , Animais , Neoplasias do Sistema Biliar/radioterapia , Antígeno Carcinoembrionário , Carcinoma Hepatocelular/tratamento farmacológico , Neoplasias do Colo/radioterapia , Doxorrubicina/uso terapêutico , Ferritinas/imunologia , Fluoruracila/uso terapêutico , Humanos , Imunodifusão , Neoplasias Hepáticas/tratamento farmacológico , Neoplasias Hepáticas/secundário , Neoplasias Hepáticas Experimentais/radioterapia , Ratos , Neoplasias Retais/radioterapiaRESUMO
One of the requirements for patentability of an invention is that the invention involves an inventive step or in other words, is not obvious. In recent years, the obviousness of inventions in biotechnology has had to be judicially considered as a consequence of new methodologies being applied in biotechnology. This paper addresses how a research worker might go about assessing whether his or her invention is obvious in the light of developments in this area of patent law.
Assuntos
Biotecnologia/legislação & jurisprudência , Patentes como Assunto/legislação & jurisprudência , Austrália , DNA Recombinante , Humanos , Pesquisa/normas , Reino Unido , Estados UnidosRESUMO
The gene encoding pilin of Bacteroides nodosus 340 has been isolated and the nucleotide sequence determined. The gene is present as a single copy within the B. nodosus genome and a protein of Mr 16683 can be predicted from the proposed coding region. A comparison of the predicted amino acid sequence with pilin from other strains of B. nodosus indicated that the protein of strain 340 (serogroup D) has a high degree of similarity with pilin of strain 265 (serogroup H). The degree of similarity between pilins from these strains and from other B. nodosus serogroups is no greater than that between B. nodosus pilins and the homologous proteins of several different bacterial species. These findings suggest that serogroups D and H may form a subset of B. nodosus serogroups.
Assuntos
Proteínas da Membrana Bacteriana Externa/genética , Bacteroides/genética , Genes Bacterianos , Sequência de Aminoácidos , Bacteroides/classificação , Sequência de Bases , DNA Bacteriano , Proteínas de Fímbrias , Dados de Sequência MolecularRESUMO
A method is described enabling the direct measurement of vincristine resistance in intact tissues in vivo by morphological study. Using the metaphase arresting properties of the drug, counts were made of escaping anaphase and telophase mitotic figures at a range of doses. The proportion of post-metaphase mitotic figures is called the post-metaphase index (PMI). In 95 primary intestinal tumours induced by dimethylhydrazine (DMH) in rats, an increase in resistance to vincristine was shown over normal mucosa (P less than 0.001). The data were analysed by computer modelling and a linear relationship is demonstrated between the logit of the post-metaphase index, and log dose of vincristine. To achieve a PMI of 1% the fitted lines show an enhanced vincristine dose requirement over normal mucosa of 6 times in colonic tumours, and 8 times in small intestinal tumours. Non-neoplastic mucosa from the DMH-treated animals requires an enhanced dose of vincristine of 1.5 times, compared with normal mucosa, to achieve a PMI of 1%. Given current interest in the mechanism of vincristine resistance in cell lines this new approach provides a technique for assessing the resistance of solid tumours, both in vivo and in vitro, and for subsequent experimental manipulation.
Assuntos
Neoplasias Intestinais/tratamento farmacológico , Vincristina/uso terapêutico , Animais , Contagem de Células , Dimetilidrazinas , Relação Dose-Resposta a Droga , Resistência a Medicamentos , Mucosa Intestinal/efeitos dos fármacos , Neoplasias Intestinais/induzido quimicamente , Masculino , Metáfase , Mitose/efeitos dos fármacos , Ratos , Ratos EndogâmicosRESUMO
The successful development of a long-term organ culture system has made it possible to perform experiments on rat colonic mucosa in vitro. However, the effect of trauma or the withdrawal of trophic influences in culture may result in the disturbance of proliferation within the tissue. In this paper we describe an investigation designed to characterise the culture system by a comparison of the proliferative parameters in vitro with those in vivo. Stathmokinetic experiments were performed in vivo and in vitro to estimate cell birth rate. Mitotic indices were also calculated. The in vivo birth rate (7.8 +/- 0.8 cells/1000 cells/hour) and the in vitro birth rate for the whole explant (7.7 +/- 0.5 cells/1000 cells/hour) were found to be similar. A study of crypts in the centre and at the edge of the cultured explants, however, indicated that proliferation at the two sites differed markedly, the birth rate at the edge (7.5 +/- 0.9 cells/1000 cells/hour) being approximately twice that at the centre (3.2 +/- 0.9 cells/1000 cells/hour). Provided that this topological difference in proliferation within the explant is recognised the in vitro model, in particular the basal level found at the centre, may still be regarded as a valid system for studying tissue responses to carcinogens and trophic factors.
Assuntos
Colo/citologia , Mucosa Intestinal/citologia , Animais , Divisão Celular , Masculino , Índice Mitótico , Técnicas de Cultura de Órgãos , Ratos , Ratos EndogâmicosRESUMO
The in-vitro effects of hydroxyurea 5-FU and 5-FUdR have been extensively studied in experimental systems employing cell-line techniques. In this study we investigated the effects of these drugs on the levels of incorporation of labeled nucleosides into DNA in explants of intact rat colonic mucosa maintained in organ culture. The effects of the nucleoside transport inhibitors nitrobenzylthioinosine (NBMPR) and dipyridamole--which are modulators of antimetabolite cytotoxicity--on the incorporation of tritiated thymidine ([3H]TdR) into DNA were also studied. The incorporation of tritiated TdR into DNA was reduced by hydroxyurea but was not altered by either 5-FU or 5-FUdR. The levels of tritiated deoxyuridine were reduced by 5-FU and 5-FUdR in separate experiments; this is in keeping with thymidylate synthase inhibition. NBMPR and dipyridamole also reduced 3H-TdR incorporation into DNA. These results can be explained in terms of the known mechanisms of action of these drugs. This experimental model is therefore useful in assessing the effects of antimetabolites and nucleoside transport inhibitors in intact colonic mucosa.
Assuntos
Colo/efeitos dos fármacos , Dipiridamol/farmacologia , Hidroxiureia/farmacologia , Mucosa Intestinal/efeitos dos fármacos , Pirimidinas/farmacologia , Tioinosina/análogos & derivados , Animais , Transporte Biológico/efeitos dos fármacos , Transporte Biológico/fisiologia , Colo/metabolismo , Colo/fisiologia , DNA/metabolismo , Mucosa Intestinal/metabolismo , Mucosa Intestinal/fisiologia , Masculino , Modelos Biológicos , Nucleosídeos/metabolismo , Nucleosídeos/farmacocinética , Técnicas de Cultura de Órgãos , Ratos , Ratos Endogâmicos , Tioinosina/farmacologia , Timidina/metabolismo , Timidina/farmacocinética , Fatores de Tempo , Trítio , Uridina/metabolismo , Uridina/farmacocinéticaRESUMO
The development of an organ-culture system for rat colonic mucosa has enabled a direct assessment of the effect of epidermal growth factor (EGF) on cell division. An augmented mitotic index (AIm) has been employed to identify changes in cell proliferation. Explants of colonic mucosa from four animals were maintained in a medium containing serum for five days. On the fifth day of culture, half of the explants received fresh medium containing EGF (40 ng/ml) and the remainder (controls) fresh medium only. At 6, 12, 24 and 48 hr thereafter groups of both experimental and control explants received the metaphase-arresting drug vincristine (4 micrograms/ml) for 3 hr prior to fixation. The proportions of vincristine-arrested metaphases within the explants were determined. Analysis of the data indicates that when serum is present exogenous EGF exerts a trophic effect which increases with time (P less than 0.001). In a second experiment colonic explants from four animals were maintained for five days in a serum-free medium and were then divided into groups, each of which received one of a range of concentrations of EGF. The AIm was determined for each group after 36 hr. It was found that increasing concentrations of EGF produce a small but significant increase in cell proliferation (P less than 0.01). This effect, however, was less pronounced than that seen when serum was present. These results suggest that EGF has a trophic action on the colon and interacts with additional factors found in serum.
Assuntos
Colo/citologia , Fator de Crescimento Epidérmico/farmacologia , Mucosa Intestinal/citologia , Animais , Sangue , Divisão Celular/efeitos dos fármacos , Colo/efeitos dos fármacos , Meios de Cultura , Mucosa Intestinal/efeitos dos fármacos , Cinética , Masculino , Índice Mitótico , Técnicas de Cultura de Órgãos , Ratos , Ratos EndogâmicosRESUMO
3H-thymidine labelling studies and a computer simulation have been employed to assess proliferative status and cellular organisation in colonic explants maintained in culture for 5 to 7 days. The one-hour flash labelling index (Is) for crypts within the middle region of explants (5.2%) was considerably lower than that observed in vivo (8.8%). Crypt length and the distribution of labelled cells appeared similar for both situations. A computer simulation program for crypt-cell proliferation was devised, facilitating the modulation of a number of parameters including the cell-cycle time (Tc) and its component phases, the cut-off position, and cell loss at mitosis. This simulation was employed to model continuous labelling (72 h) data obtained in vitro and provided an estimate of various kinetic parameters. Data for the middle region of explants was fitted with a Tc of 62 h, an S phase of 8 h and a cell loss factor (20%) which was consistent with histological findings. A fit to the experimental data obtained in vitro could be achieved by a model based upon a mode of cellular organisation known to occur within crypts in vivo. Therefore in vitro, the dynamic processes of crypt-cell proliferation and migration appear to be organised in the same manner as seen in vivo.
Assuntos
Colo/citologia , Simulação por Computador , Animais , Divisão Celular , Colo/patologia , Masculino , Mucosa/citologia , Mucosa/patologia , Técnicas de Cultura de Órgãos , Ratos , Ratos Endogâmicos , Contagem de Cintilação , TimidinaRESUMO
A library of seven monoclonal antibodies has been prepared against rat brain hexokinase (ATP:D-hexose 6-phosphotransferase, EC 2.7.1.1). Four of these antibodies, all of the IgG class, react with both native hexokinase and, to a more limited extent, with a ureadenatured S-carboxymethylated form of the enzyme. The other three antibodies, all of the IgM class, react readily with the denatured enzyme but are quite ineffective at binding native hexokinase. The monoclonal IgGs were further characterized with respect to their effects on certain functional properties of hexokinase. None had any detectable effect on catalytic properties, including inhibition by glucose 6-phosphate. One of the antibodies, designated 3C, totally blocked binding of the enzyme to the mitochondrial membrane, and significantly enhanced the release of the mitochondrially bound enzyme in either the absence or presence of glucose 6-phosphate, a ligand which promotes solubilization of mitochondrial hexokinase. It was concluded that the epitope recognized by 3C lies in, or immediately adjacent to, the region of the hexokinase molecule directly involved in interaction with the mitochondrial membrane. Two other IgGs, designated 1B and 2B, had only marginal effects on the binding of hexokinase to mitochondria, but were highly effective in preventing solubilization of the mitochondrially bound hexokinase by glucose 6-phosphate. Since these antibodies did not prevent binding of this ligand, as evidenced by the lack of an effect on inhibition, it is suggested that the effect of 1B and 2B on glucose 6-phosphate-induced solubilization is due to selective modification of the conformational changes that result from binding of glucose 6-phosphate. The monoclonal IgG designated 13 had no appreciable effect on either binding or glucose 6-phosphate-induced solubilization. The epitope for 13 is thought to lie in a "neutral" region of the hexokinase molecule, not involved in either catalytic or membrane-binding functions of the enzyme.
Assuntos
Anticorpos Monoclonais , Encéfalo/enzimologia , Hexoquinase/metabolismo , Membranas Intracelulares/enzimologia , Mitocôndrias/enzimologia , Animais , Complexo Antígeno-Anticorpo , Hexoquinase/imunologia , Imunoglobulina G , Imunoglobulina M , Cinética , Mitocôndrias Hepáticas/enzimologia , RatosRESUMO
Kinetic parameters on dihydroorotate dehydrogenase (DHO-DHase) from the rodent malarial parasite, Plasmodium berghei, have been determined. This enzyme, the fourth in de novo pyrimidine biosynthesis, is particulate and is absent in the mature mammalian red cell. The Km of the substrate, dihydroorotate, was determined to be 23 microM and the Ki values for a number of substrate analogues have been determined. The most potent inhibitor was dihydroazaorotate (Ki, 3 microM), 5-azaorotate (Ki, 20 microM) and other pyrimidine analogues. The activity of the enzyme was also affected by a number of respiratory chain inhibitors. As the P. berghei infection is accompanied by reticulocytosis, a comparative study of DHO-DHase in mouse reticulocytes was also carried out. The general properties of the enzyme from these sources were similar to those of the parasite enzyme. However, significant differences in the response of the two enzymes to various inhibitors were observed and could provide a rational basis for the development of chemotherapeutic agents active against the parasite.
Assuntos
Di-Hidrorotato Oxidase/metabolismo , Oxirredutases/metabolismo , Plasmodium berghei/enzimologia , Reticulócitos/enzimologia , Animais , Radioisótopos de Carbono , Cinética , Camundongos , Purinas/farmacologia , Pirimidinas/farmacologia , Ribonucleotídeos/farmacologiaRESUMO
Sulindac, a non-steroidal anti-inflammatory drug, has been reported to lead to tumour regression in cases of human polyposis coli. We have investigated the effects of this drug on the growth of 1,2-dimethylhydrazine (DMH)-induced mouse colonic tumours. In one experiment, DMH and oral sulindac were administered concurrently to a group of mice for a period of up to 24 weeks, while a control group of animals received DMH only for the same period. Sulindac caused a significant reduction in both the number of mice with colonic tumours and the number of tumours per mouse. In a second experiment, two groups of mice which had already been treated with DMH for 17 weeks received either sulindac or not for 78 days. In this experiment sulindac had no effect. These results demonstrate that sulindac has a protective effect against the chemical induction of colonic tumours in mice, but does not cause the regression of established tumours.